Demographic, clinical and laboratory features of active GIBS patients and in GIBS patients who are in remission
| Active GIBS | GIBS in remission | P value | |
|---|---|---|---|
| (n=14) | (n=25) | ||
| Gender, M/F | 5/9 | 10/15 | 0.15 |
| Mean±SD age, years | 47.5±7.2 | 40±11 | 0.03 |
| Median (IQR) FC, μg/g | 301 (176–957) | 30 (30–134) | <0.001 |
| FC ≥150 μg/g, n (%) | 12 (86) | 6 (24) | <0.001 |
| Median (IQR) serum calprotectin, ng/mL | 98 (39–128) | 69 (54–101) | 0.5 |
| Median (IQR) serum CRP, mg/dL | 2 (1–5) | 3 (2–15) | 0.07 |
| Median (IQR) CDAI scores | 52 (4–189) | 30 (0–92) | 0.2 |
| Median (IQR) DAIBD scores | 40 (4–81) | 20 (0–37) | 0.1 |